Today: 15 June 2026
Elong Power Stock Jumps 72% As Lock-Up Expiry Puts ELPW Share Supply In Focus
4 May 2026
2 mins read

Elong Power Stock Jumps 72% As Lock-Up Expiry Puts ELPW Share Supply In Focus

BEIJING, China, May 5, 2026, 01:03 (China Standard Time)

Elong Power Holding Limited’s Nasdaq-listed shares jumped about 72% in Monday midday trading, with volume above 32 million shares, as investors weighed a fresh lock-up expiry report for the battery-energy storage company. MarketScreener, citing S&P Capital IQ, reported that restrictions ended May 4 on 3,844,867 Class A ordinary shares and 361,090 Class B ordinary shares.

The timing matters because a lock-up is a set period when holders agree not to sell. When it ends, supply can become a live issue. Elong has warned in an SEC filing that sales of substantial amounts of Class A shares after lock-ups, or the perception that such sales could happen, could hurt its share price and make future equity raises harder.

The shares opened at $4.56, touched $10.14 and were last quoted at $7.59, up $3.17 on the day, according to market data. That move came while Nasdaq trading was still underway in New York.

The lock-up report said the covered shares had been restricted for 91 days, from Feb. 2 to May 4. It said directors and executive officers had agreed to a 90-day period in which they could not sell, encumber or otherwise dispose of covered securities without prior written consent from the underwriter.

The expiry lands after a run of financing and share-structure changes. On Feb. 3, Elong said it closed a $7.6 million public offering of 2.4 million units at $3.16 each, with each unit including one Class A share and one warrant; the warrants carried reset terms and a “zero exercise price” option, meaning holders could receive shares without paying more cash under the warrant terms.

More dilution followed. In a March 9 filing, Elong said all 24.955 million warrants from a separate March 2 issuance had been exercised through the zero-exercise option, leading to 77,764,364 new Class A shares. Days later, the company approved an 80-for-one share consolidation, a reverse split that combines shares to lift the price per share, cutting outstanding Class A shares to about 1.4 million and Class B shares to about 4,514.

Nasdaq compliance is still part of the story. Elong moved its Class A shares from the Nasdaq Global Market to the Nasdaq Capital Market effective April 1 and said Nasdaq had closed two market-value compliance matters after the transfer.

The company is not just changing its share count. In its 2025 annual report, Elong said it sold Elong Power International Co. and related subsidiaries for $10,000, citing slower growth and rising losses in battery packs, battery cells and spare parts, and said it would focus on research, development, sales and service of energy storage systems.

For 2025, Elong reported revenue of $2.05 million and a net loss of $5.57 million, narrowing from a $30.11 million loss in 2024. The revenue came mainly from trading and sales of energy storage batteries, part of what the company called an updated business strategy.

But the balance sheet remains a risk. Enrome LLP, the auditor, flagged a “material uncertainty related to going concern” — auditor language that means there is doubt about a company’s ability to keep operating normally — after Elong posted negative operating cash flow of $2.66 million and had a $14.0 million working capital deficit at the end of 2025.

The competitive backdrop is also tough. Elong’s annual report named CATL, BYD and Sungrow among larger battery-storage rivals and said the market is intensely competitive, with price pressure that could cut gross margins. That leaves Monday’s stock move tied less to a single operating milestone than to supply, liquidity and the company’s ability to fund a smaller, refocused business.

Stock Market Today

  • Australia's Sigma Healthcare Ends Talks to Acquire UK Pharmacy Chain Boots
    June 14, 2026, 9:36 PM EDT. Australia's Sigma Healthcare has ended preliminary acquisition talks with British pharmacy chain Boots, determining the deal would not align with its strategic and capital investment objectives. Sigma Healthcare disclosed the decision on Monday, signaling a shift away from expanding its footprint through this potential overseas purchase. Boots, a major UK pharmacy retailer, had been under consideration as Sigma Healthcare evaluated international growth opportunities. The move highlights Sigma's focus on maintaining disciplined investment criteria amid an evolving global healthcare retail market.

Latest articles

Dow Futures Tick Up, Oil Drops After U.S.-Iran Deal, SpaceX IPO in Focus

Dow Futures Tick Up, Oil Drops After U.S.-Iran Deal, SpaceX IPO in Focus

15 June 2026
Dow, S&P 500, and Nasdaq futures rose Sunday evening after reports of a U.S.-Iran peace deal that would reopen the Strait of Hormuz, sending oil prices down over 4% as traders anticipated resumed energy shipments; SpaceX shares surged 19.2% in their Nasdaq debut, closing at $160.95 and pushing market cap above $2 trillion, while investors await confirmation of the deal and details on shipping normalization.
Asia Opens June 16 as Oil Gains, BOJ and Fed Moves Loom

Asia Opens June 16 as Oil Gains, BOJ and Fed Moves Loom

15 June 2026
Brent crude plunged 4.02% to $83.82 and WTI fell 4.63% to $80.95 after the U.S. and Iran reached a deal to halt the war and reopen the Strait of Hormuz, easing inflation pressure and lifting profit expectations for Asian equities, but execution risks remain with the deal’s terms incomplete and potential for oil to rebound if tensions flare. (Reuters)
Fed, Oil Prices, and SpaceX Draw Attention Prior to Tuesday’s Open

Fed, Oil Prices, and SpaceX Draw Attention Prior to Tuesday’s Open

15 June 2026
U.S. stocks face key risks as investors await the June 16–17 Fed meeting, with inflation at 4.2% and Brent crude at $86.80; the U.S.-Iran deal could lower oil prices and ease inflation, but uncertainty over terms and Fed policy keeps markets volatile, while SpaceX’s 19.2% Nasdaq debut signals strong demand for AI-linked growth stocks. (Reuters)
Dow Jones Today: Blue-Chip Index Slides 500 Points as Oil Shock Hits Wall Street
Previous Story

Dow Jones Today: Blue-Chip Index Slides 500 Points as Oil Shock Hits Wall Street

Figma Stock Jumps Ahead of Earnings as AI Design Fight Gets Real
Next Story

Figma Stock Jumps Ahead of Earnings as AI Design Fight Gets Real

Go toTop